AAAAAA
Results: 1-25/27
Authors:
WOLL PJ
Citation: Pj. Woll, SMOKING AND RISK OF MYOCARDIAL-INFARCTION - SMOKING IS A FEMINIST ISSUE, BMJ. British medical journal, 317(7164), 1998, pp. 1018-1018
Authors:
LANGLEY RE
CARMICHAEL J
WOLL PJ
MASON E
WELBANK H
Citation: Re. Langley et al., PHASE-II TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF CAELYX(R) (DOXIL(R)) IN COMBINATION WITH PACLITAXEL IN THE TREATMENT OF METASTATIC CANCER, Annals of oncology, 9, 1998, pp. 652-652
Authors:
WEAVER A
CHANG J
WRIGLEY E
DEWYNTER E
WOLL PJ
LIND M
JENKINS B
GILL C
WILKINSON PM
PETTENGELL R
RADFORD JA
COLLINS CD
DEXTER TM
TESTA NG
CROWTHER D
Citation: A. Weaver et al., RANDOMIZED COMPARISON OF PROGENITOR-CELL MOBILIZATION USING CHEMOTHERAPY, STEM-CELL FACTOR, AND FILGRASTIM OR CHEMOTHERAPY PLUS FILGRASTIM ALONE IN PATIENTS WITH OVARIAN-CANCER, Journal of clinical oncology, 16(8), 1998, pp. 2601-2612
Authors:
THATCHER N
LEE SM
WOLL PJ
MIDDLETON M
ANDERSON H
BURT P
STOUT R
Citation: N. Thatcher et al., DOSE INTENSITY IN SMALL-CELL LUNG-CANCER, Seminars in oncology, 25(2), 1998, pp. 12-18
Authors:
WHITE JD
CARMICHAEL J
WOLL PJ
GUILFORD T
RUSSELL RC
Citation: Jd. White et al., PHASE 1B STUDY OF CONCURRENT ADMINISTRATION OF MARIMASTAT AND GEMCITABINE IN NONRESECTABLE PANCREATIC-CANCER, British Journal of Cancer, 78, 1998, pp. 7-7
Authors:
FYFE D
REYNAUD F
WHITE J
CLAYTON K
MASON L
GARDNER C
WOLL PJ
JUDSON I
CARMICHAEL J
Citation: D. Fyfe et al., A PILOT PHARMACOKINETIC STUDY OF AMSALOG (CI-921) ADMINISTERED ORALLYON A 5 DAY SCHEDULE, British Journal of Cancer, 78, 1998, pp. 27-27
Authors:
LEONARD RCF
SMITH IE
COLEMAN RE
MALPAS JS
NICOLSON M
CASSIDY J
JONES A
MCILLMURRAY MB
STUART NSA
WOLL PJ
WHITEHOUSE JMA
Citation: Rcf. Leonard et al., MORE MONEY IS NEEDED TO CARE FOR PATIENTS WITH CANCER, BMJ. British medical journal, 315(7111), 1997, pp. 811-812
Authors:
LANGLEY RE
WOLL PJ
DAVIDSON N
LIBRETTI V
SMYTH JF
SCHIPPER R
CARMICHAEL J
Citation: Re. Langley et al., PHASE-II STUDY OF PACLITAXEL AS FIRST LINE TREATMENT FOR PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER (SCLC), European journal of cancer, 33, 1997, pp. 1040-1040
Authors:
LACKO A
WOLL PJ
LANGLEY RE
THOMAS A
CARMICHAEL J
Citation: A. Lacko et al., CEF CHEMOTHERAPY FOR ADVANCED GASTROESOPHAGEAL CANCER, European journal of cancer, 33, 1997, pp. 1272-1272
Authors:
WEAVER A
WOLL PJ
LIND M
GILL C
JENKINS B
DEXTER TM
TESTA NG
CROWTHER D
Citation: A. Weaver et al., STEM-CELL FACTOR (R-METHUSCF) IN COMBINATION WITH FILGRASTIM (R-METHUG-CSF) ENHANCES PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZATION FOLLOWING CHEMOTHERAPY - A RANDOMIZED STUDY, European journal of cancer, 33, 1997, pp. 7-7
Authors:
THOMAS AL
WOLL PJ
Citation: Al. Thomas et Pj. Woll, CYTOTOXIC DOSE-RESPONSE RELATIONSHIPS IN SMALL-CELL LUNG-CANCER, Cancer treatment reviews, 23(4), 1997, pp. 191-207
Authors:
WOLL PJ
Citation: Pj. Woll, INTERFERONS IN ONCOLOGY (VOL 51, PG 111, 1997), British journal of clinical practice, 51(3), 1997, pp. 146-146
Authors:
WOLL PJ
PETTENGELL R
Citation: Pj. Woll et R. Pettengell, INTERFERONS IN ONCOLOGY, British journal of clinical practice, 51(2), 1997, pp. 111-115
Authors:
WOLL PJ
BASSER R
LECHEVALIER T
DRINGS P
MANGA GP
ADENIS A
SEYMOUR L
SMITH F
THATCHER N
Citation: Pj. Woll et al., PHASE-II TRIAL OF RALTITREXED (TOMUDEX) IN ADVANCED SMALL-CELL LUNG-CANCER, British Journal of Cancer, 76(2), 1997, pp. 264-265
Authors:
PETTENGELL R
RADFORD JA
MORGENSTERN GR
SCARFFE JH
HARRIS M
WOLL PJ
DEAKIN DP
RYDER D
WILKINSON PM
CROWTHER D
Citation: R. Pettengell et al., SURVIVAL BENEFIT FRONT HIGH-DOSE THERAPY WITH AUTOLOGOUS BLOOD PROGENITOR-CELL TRANSPLANTATION IN POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 14(2), 1996, pp. 586-592
Authors:
VERWEIJ J
MOURIDSEN HT
NIELSSEN OS
WOLL PJ
SOMERS R
VANOOSTEROM AT
VANGLABBEKE M
TURSZ T
Citation: J. Verweij et al., THE PRESENT STATE-OF-THE-ART IN CHEMOTHERAPY FOR SOFT-TISSUE SARCOMASIN ADULTS - THE EORTC POINT-OF-VIEW, Critical reviews in oncology/hematology, 20(3), 1995, pp. 193-201
Authors:
WOLL PJ
HART IR
Citation: Pj. Woll et Ir. Hart, GENE-THERAPY FOR LUNG-CANCER, Annals of oncology, 6, 1995, pp. 73-77
Authors:
WOLL PJ
HODGETTS J
LOMAX L
BILDET F
COURCHABERNAUD V
THATCHER N
Citation: Pj. Woll et al., CAN CYTOTOXIC DOSE-INTENSITY BE INCREASED BY USING GRANULOCYTE-COLONY-STIMULATING FACTOR - A RANDOMIZED CONTROLLED TRIAL OF LENOGRASTIM IN SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 13(3), 1995, pp. 652-659
Authors:
PETTENGELL R
WOLL PJ
THATCHER N
DEXTER TM
TESTA NG
Citation: R. Pettengell et al., MULTICYCLIC, DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED BY SEQUENTIAL REINFUSION OF HEMATOPOIETIC PROGENITORS IN WHOLE-BLOOD, Journal of clinical oncology, 13(1), 1995, pp. 148-156
Authors:
WOLL PJ
CROWTHER D
JOHNSON PWM
SOUKOP M
HARPER PG
HARRIS M
BRAMPTON MH
NEWLANDS ES
Citation: Pj. Woll et al., PHASE-II TRIAL OF TEMOZOLOMIDE IN LOW-GRADE NON-HODGKINS-LYMPHOMA, British Journal of Cancer, 72(1), 1995, pp. 183-184
Authors:
WOLL PJ
RANSON M
MARGISON J
THOMSON Y
VANDERWATER L
GEORGE N
HOWELL A
Citation: Pj. Woll et al., SURAMIN FOR BREAST AND PROSTATE-CANCER - A PILOT-STUDY OF INTERMITTENT SHORT INFUSIONS WITHOUT ADAPTIVE-CONTROL, Annals of oncology, 5(7), 1994, pp. 597-600
Authors:
PETTENGELL R
WOLL PJ
OCONNOR DA
DEXTER TM
TESTA NG
Citation: R. Pettengell et al., VIABILITY OF HEMATOPOIETIC PROGENITORS FROM WHOLE-BLOOD, BONE-MARROW AND LEUKAPHERESIS PRODUCT - EFFECTS OF STORAGE MEDIA, TEMPERATURE AND TIME, Bone marrow transplantation, 14(5), 1994, pp. 703-709
Authors:
PETTENGELL R
WOLL PJ
CHANG J
COUTINHO L
TESTA NG
CROWTHER D
Citation: R. Pettengell et al., EFFECTS OF ERYTHROPOIETIN ON MOBILIZATION OF HEMATOPOIETIC PROGENITORCELLS, Bone marrow transplantation, 14(1), 1994, pp. 125-130
Authors:
VANHOEF MEHM
RADFORD JA
JONES A
SMITH IE
EARL HM
WOLL PJ
THATCHER N
Citation: Mehm. Vanhoef et al., URINARY-DERIVED MONOCYTE-COLONY STIMULATING FACTOR (P-100) FOLLOWING TREATMENT WITH CARBOPLATIN AND ETOPOSIDE IN SMALL-CELL LUNG-CANCER (SCLC), Annals of oncology, 4(10), 1993, pp. 877-881
Authors:
WOLL PJ
Citation: Pj. Woll, GROWTH-FACTORS, ANTAGONISTS AND LUNG-CANCER, Journal of the Royal Society of Medicine, 86(11), 1993, pp. 621-622